Integral Health Asset Management, LLC Penumbra Inc Transaction History

Integral Health Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$220.09 - $273.15 $6.6 Million - $8.19 Million	30,000 Added 75.0%	70,000 $15.6 Million
Q4 2023 Feb 14, 2024	BUY	$181.44 - $260.22 $7.26 Million - $10.4 Million	40,000 New	40,000 $10.1 Million
Q2 2023 Aug 11, 2023	SELL	$271.54 - $344.06 $1.36 Million - $1.72 Million	-5,000 Reduced 14.29%	30,000 $10.3 Million
Q1 2023 May 09, 2023	BUY	$220.43 - $278.69 $1.1 Million - $1.39 Million	5,000 Added 16.67%	35,000 $9.75 Million
Q4 2022 Feb 13, 2023	BUY	$151.88 - $228.5 $4.56 Million - $6.86 Million	30,000 New	30,000 $6.67 Million

375

29.1M

305K

192K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.5B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Integral Health Asset Management, LLC with notifications on news.